• Thailand’s experience and historical developments with cancer and ARV drugs important to demonstrating the negotiation processes with pharmaceuticals and with utilizing CL to increase access to care and increase pT life expectancy, in addition to saving billions of baht
• Price products in relation to the context and capabilities of each country